Cel
Cancer is a worldwide health burden and represents a major public health challenge in Europe. It is responsible for 25% of all deaths, being the second most common cause of death after cardio-vascular diseases and the main cause of mortality among people aged 45–64. Today, an estimated 9 million individuals in Europe live with cancer (Globocan 2008, http://globocan.iarc.fr/). Cancer became a chronic disease which contributed substantially to the growth of medical expenditures and constitutes a major socio-economic challenge for Europe as well as globally. A rapid and effective bidirectional transfer of relevant cancer research findings between bench and bedside would play a pivotal role in addressing top-priority needs at the EU level to reduce incidence and mortality of malignancies and to improve the quality of life of cancer patients.
The proposed ERA-NET Cofund TRANSCAN-2, in continuity with the preceding and ongoing TRANSCAN ERA-NET, aims at linking translational cancer research funding programmes in 15 Member States, 3 Associated Countries, and a third country. By concentrating transnational resources, TRANSCAN-2 will provide a critical financial and scientific mass for tackling large-scale problems, relevant for improving translational cancer research globally.
A co-funded joint transnational call (JTC) will be launched focusing on the topic “Intratumour heterogeneity in resistance to therapy and recurrence” followed by three additional JTCs that will be implemented in a frame of multinational translational cancer research programmes. In addition, strategies will be developed for the enlargement of the network, for improvement of coordination and for an efficient communication and dissemination of the results of the consortium as well as of the research projects funded through the JTCs. The monitoring of the projects funded through the JTCs and the critical assessment of the performance of TRANSCAN-2, based on key indicators, will be also realised.
Program(-y)
Zaproszenie do składania wniosków
Zobacz inne projekty w ramach tego zaproszeniaSzczegółowe działanie
H2020-HCO-2014
System finansowania
ERA-NET-Cofund - ERA-NET CofundKoordynator
00144 Roma
Włochy
Zobacz na mapie
Uczestnicy (33)
1010 Wien
Zobacz na mapie
00161 Roma
Zobacz na mapie
Zakończenie uczestnictwa
1050 Riga
Zobacz na mapie
92513 Boulogne Billancourt
Zobacz na mapie
53175 Bonn
Zobacz na mapie
51147 Koln
Zobacz na mapie
94800 Villejuif
Zobacz na mapie
115 10 ATHENS
Zobacz na mapie
9101002 Jerusalem
Zobacz na mapie
00144 Roma
Zobacz na mapie
2593 CE DEN HAAG
Zobacz na mapie
1062 EA AMSTERDAM
Zobacz na mapie
0283 Oslo
Zobacz na mapie
1249 074 Lisboa
Zobacz na mapie
814 38 Bratislava
Zobacz na mapie
1000 Ljubljana
Zobacz na mapie
28029 Madrid
Zobacz na mapie
06100 Ankara
Zobacz na mapie
00-801 WARSZAWA
Zobacz na mapie
1000 Bruxelles / Brussel
Zobacz na mapie
1122 Budapest
Zobacz na mapie
0153 Oslo
Zobacz na mapie
1000 Bruxelles / Brussel
Zobacz na mapie
Zakończenie uczestnictwa
00153 Roma
Zobacz na mapie
51004 Tartu
Zobacz na mapie
33007 Oviedo
Zobacz na mapie
106 Taipei
Zobacz na mapie
1050 Riga
Zobacz na mapie
50122 Firenze
Zobacz na mapie
Podmiot prawny inny niż podwykonawca, stowarzyszony lub mający inne powiązania prawne z uczestnikiem. Podmiot realizuje prace na podstawie warunków umowy o grant, dostarcza towary lub świadczy usługi związane z działaniem, jednak nie podpisuje umowy o grant. Podmiot zewnętrzny przestrzega zasad i wymogów dotyczących danego uczestnika wynikających z umowy o grant, dotyczących kwalifikowalności kosztów oraz kontroli wydatków.
53100 Siena
Zobacz na mapie
20124 Milano
Zobacz na mapie
28045 Madrid
Zobacz na mapie
00153 Roma
Zobacz na mapie